Annual Meeting of Thai Cerebrovascular Surgeons

At the Thai Cerebrovascular Surgery Meeting (TCVS) 2024 on November 7, Genfosis CEO Dr. Sacarin Bunbanjerdsuk detailed how genomics will shape the future of neurovascular surgery. In his presentation, titled “The Future of Neurovascular Surgery: Genomics and Tech Innovation,” he highlighted the use of genetic data to create personalized treatments and enable early risk detection for conditions like stroke, marking a shift towards more proactive patient care.